News


Calyxt to Present at Upcoming Conferences

Calyxt to Present at Upcoming Conferences

ROSEVILLE, Minn., May 17, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that management will participate in the...
Read More
Calyxt Reports First Quarter 2022 Financial Results

Calyxt Reports First Quarter 2022 Financial Results

Achieved technical BioFactory™ and AIML milestones to support customer demand-driven molecule development at scale Progressed relationships with an expanding network...
Read More
Calyxt Announces Strategic Hires in Business Development and Manufacturing

Calyxt Announces Strategic Hires in Business Development and Manufacturing

Continued investment in key hires to strategically position Company for future growth and scale ROSEVILLE, Minn., April 26, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq:...
Read More
Calyxt to Host First Quarter 2022 Financial Results Conference Call and Webcast on Thursday, May 5, 2022, at 4:30 p.m. Eastern Time

Calyxt to Host First Quarter 2022 Financial Results Conference Call and Webcast on Thursday, May 5, 2022, at 4:30 p.m. Eastern Time

ROSEVILLE, Minn., April 21, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will host a conference call and webcast on...
Read More
Calyxt Management Joins HCW @ Home for Virtual Fireside Chat

Calyxt Management Joins HCW @ Home for Virtual Fireside Chat

Roseville, MN – Tuesday, April 19, 2022 – Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, participated recently in...
Read More
Next »